On Thursday, Sellas said that it received approximately $26.5 million in proceeds from the exercise of common stock warrants.

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window SAN DIEGO -- ...

Cancer’s cruelest trick is its ability to disappear, only to reappear years later in a new organ or a familiar scar. The fear ...

The study covered in this summary was published on ssrn.com as a preprint and has not yet been peer reviewed. Cytarabine plus an anthracycline has been the standard AML induction regimen for decades, ...

A new immunotherapy treatment for advanced melanoma had a reduction in disease progression in 50 percent of participants and complete remission in 20 percent, making it one of the most effective ...

As soon as I entered complete remission for multiple myeloma, I felt a glimmer of hope. The word "remission" carries a sense of hope and relief, like the first ray of sunshine breaking through the ...

Please provide your email address to receive an email when new articles are posted on . Treatment with CTX130, a novel chimeric antigen receptor T-cell therapy, led to disease control in more than ...

Many patients with late-stage blood cancers receiving an experimental T-cell therapy went into complete remission, according to preliminary research results from a Fred Hutchinson Cancer Research ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Complete remission at 8 weeks was observed in patients ...

Hematologist-oncologist Leonard Klein had good news for his patient, a 65-year old woman with multiple myeloma. After chemotherapy and a stem-cell transplant, her disease was in complete remission.